ahlam1399
09-23-2015, 07:41 PM
UPDATE 1-Amgen, Allergan say Avastin copycat succeeds in lung cancer study
Sept 23 (Reuters) - Amgen Inc and Allergan Plc said a late-stage study showed their biosimilar candidate for a type of lung cancer was as effective as Roche AG's Avastin in preventing disease progression and improving survival.
http://rc.feedsportal.com/r/238386228921/u/49/f/654213/c/35217/s/4a1a3762/sc/14/rc/1/rc.img (http://rc.feedsportal.com/r/238386228921/u/49/f/654213/c/35217/s/4a1a3762/sc/14/rc/1/rc.htm)
http://rc.feedsportal.com/r/238386228921/u/49/f/654213/c/35217/s/4a1a3762/sc/14/rc/2/rc.img (http://rc.feedsportal.com/r/238386228921/u/49/f/654213/c/35217/s/4a1a3762/sc/14/rc/2/rc.htm)
http://rc.feedsportal.com/r/238386228921/u/49/f/654213/c/35217/s/4a1a3762/sc/14/rc/3/rc.img (http://rc.feedsportal.com/r/238386228921/u/49/f/654213/c/35217/s/4a1a3762/sc/14/rc/3/rc.htm)
http://da.feedsportal.com/r/238386228921/u/49/f/654213/c/35217/s/4a1a3762/sc/14/a2.img (http://da.feedsportal.com/r/238386228921/u/49/f/654213/c/35217/s/4a1a3762/sc/14/a2.htm)
http://adchoice.feedsportal.com/r/238386228921/u/49/f/654213/c/35217/s/4a1a3762/sc/14/ach.img (http://adchoice.feedsportal.com/r/238386228921/u/49/f/654213/c/35217/s/4a1a3762/sc/14/ach.htm)http://pi.feedsportal.com/r/238386228921/u/49/f/654213/c/35217/s/4a1a3762/sc/14/a2t.imghttp://pi2.feedsportal.com/r/238386228921/u/49/f/654213/c/35217/s/4a1a3762/sc/14/a2t2.imghttp://i0.wp.com/reuters.us.feedsportal.com/c/35217/f/654213/s/4a1a3762/sc/14/mf.gif?resize=1%2C1http://feeds.feedburner.com/~ff/reuters/companyNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/companyNews?a=JcsuYuPXRr0:YF7XiEefw4Q:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/companyNews?i=JcsuYuPXRr0:YF7XiEefw4Q:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/companyNews?a=JcsuYuPXRr0:YF7XiEefw4Q:V_sGLiPBpWU) http://feeds.feedburner.com/~ff/reuters/companyNews?i=JcsuYuPXRr0:YF7XiEefw4Q:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/companyNews?a=JcsuYuPXRr0:YF7XiEefw4Q:F7zBnMyn0Lo)
http://feeds.feedburner.com/~r/reuters/companyNews/~4/JcsuYuPXRr0
Sept 23 (Reuters) - Amgen Inc and Allergan Plc said a late-stage study showed their biosimilar candidate for a type of lung cancer was as effective as Roche AG's Avastin in preventing disease progression and improving survival.
http://rc.feedsportal.com/r/238386228921/u/49/f/654213/c/35217/s/4a1a3762/sc/14/rc/1/rc.img (http://rc.feedsportal.com/r/238386228921/u/49/f/654213/c/35217/s/4a1a3762/sc/14/rc/1/rc.htm)
http://rc.feedsportal.com/r/238386228921/u/49/f/654213/c/35217/s/4a1a3762/sc/14/rc/2/rc.img (http://rc.feedsportal.com/r/238386228921/u/49/f/654213/c/35217/s/4a1a3762/sc/14/rc/2/rc.htm)
http://rc.feedsportal.com/r/238386228921/u/49/f/654213/c/35217/s/4a1a3762/sc/14/rc/3/rc.img (http://rc.feedsportal.com/r/238386228921/u/49/f/654213/c/35217/s/4a1a3762/sc/14/rc/3/rc.htm)
http://da.feedsportal.com/r/238386228921/u/49/f/654213/c/35217/s/4a1a3762/sc/14/a2.img (http://da.feedsportal.com/r/238386228921/u/49/f/654213/c/35217/s/4a1a3762/sc/14/a2.htm)
http://adchoice.feedsportal.com/r/238386228921/u/49/f/654213/c/35217/s/4a1a3762/sc/14/ach.img (http://adchoice.feedsportal.com/r/238386228921/u/49/f/654213/c/35217/s/4a1a3762/sc/14/ach.htm)http://pi.feedsportal.com/r/238386228921/u/49/f/654213/c/35217/s/4a1a3762/sc/14/a2t.imghttp://pi2.feedsportal.com/r/238386228921/u/49/f/654213/c/35217/s/4a1a3762/sc/14/a2t2.imghttp://i0.wp.com/reuters.us.feedsportal.com/c/35217/f/654213/s/4a1a3762/sc/14/mf.gif?resize=1%2C1http://feeds.feedburner.com/~ff/reuters/companyNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/companyNews?a=JcsuYuPXRr0:YF7XiEefw4Q:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/companyNews?i=JcsuYuPXRr0:YF7XiEefw4Q:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/companyNews?a=JcsuYuPXRr0:YF7XiEefw4Q:V_sGLiPBpWU) http://feeds.feedburner.com/~ff/reuters/companyNews?i=JcsuYuPXRr0:YF7XiEefw4Q:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/companyNews?a=JcsuYuPXRr0:YF7XiEefw4Q:F7zBnMyn0Lo)
http://feeds.feedburner.com/~r/reuters/companyNews/~4/JcsuYuPXRr0